0001562180-21-007617.txt : 20211209
0001562180-21-007617.hdr.sgml : 20211209
20211209184222
ACCESSION NUMBER: 0001562180-21-007617
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211207
FILED AS OF DATE: 20211209
DATE AS OF CHANGE: 20211209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horstmeier Paul
CENTRAL INDEX KEY: 0001780978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38993
FILM NUMBER: 211483179
MAIL ADDRESS:
STREET 1: C/O HEALTH CATALYST, INC.
STREET 2: 3165 E. MILLROCK DRIVE #400
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst, Inc.
CENTRAL INDEX KEY: 0001636422
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 453337483
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 801-708-6800
MAIL ADDRESS:
STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
FORMER COMPANY:
FORMER CONFORMED NAME: HQC Holdings, Inc.
DATE OF NAME CHANGE: 20150312
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-12-07
false
0001636422
Health Catalyst, Inc.
HCAT
0001780978
Horstmeier Paul
C/O HEALTH CATALYST, INC.
10897 SOUTH RIVER FRONT PARKWAY, #300
SOUTH JORDAN
UT
84095
false
true
false
false
Chief Operating Officer
Common Stock
2021-12-07
4
S
false
2082.00
39.9688
D
91035.00
D
Common Stock
2021-12-07
4
S
false
400.00
40.61
D
90635.00
D
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.
Represents the weighted average sale price of the shares sold ranging from $39.46 to $40.42 per share, inclusive.
Represents the weighted average sale price of the shares sold ranging from $40.58 to $40.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
/s/ Daniel Orenstein, as Attorney-in-Fact
2021-12-09